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Behavioral/Systems/Cognitive
Endogenous Opioids and Attenuated
Hypothalamic–Pituitary–Adrenal Axis Responses to
Immune Challenge in Pregnant Rats
Paula J. Brunton,1 Simone L. Meddle,1 Shuaike Ma,2 Tomasz Ochedalski,3 Alison J. Douglas,1 and John A. Russell1
1Laboratory of Neuroendocrinology, Centre for Integrative Physiology, College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh
EH8 9XD, United Kingdom, 2Department of Pharmacology, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229-3900, and
3Institute of Gynecology and Obstetrics, Medical University of Łodz, 94-029 Łodz, Poland
In late pregnant rats, the hypothalamic–pituitary–adrenal (HPA) axis is hyporesponsive to psychogenic stressors. Here, we investigated
attenuated HPA responses to an immune challenge and a role for endogenous opioids. ACTH and corticosterone were assayed in blood
samples from virgin and 21 d pregnant rats before and after endotoxin [lipopolysaccharide (LPS); 1g/kg, i.v.], interleukin-1 (IL-1;
500 ng/kg, i.v.), or vehicle. In virgins, plasmaACTH concentrations increased 1 h after LPS and 15min after IL-1, as did corticosterone,
with no responses in pregnant rats. In situ hybridization revealed increased corticotrophin releasing hormone (CRH)mRNA expression
in the dorsomedial parvocellular paraventricular nucleus (pPVN) and increased anterior pituitary pro-opiomelanocortinmRNAexpres-
sion 4 h after IL-1 in virgins; these responses were absent in pregnant rats. In contrast, immunocytochemistry showed that Fos
expressionwas similarly increased in thenucleus tractus solitarius (NTS)A2 region invirgin andpregnant rats 90minand4hafter IL-1.
Naloxone pretreatment (5mg/kg, i.v.) restoredACTHandpPVNCRHmRNA responses after IL-1 in pregnant rats but reduced the CRH
mRNA response in virgins without affecting ACTH. Proenkephalin-A and -opioid receptor mRNA expression in the NTS was signifi-
cantly increased in thepregnant rats, indicatingupregulatedbrainstemopioidmechanisms. IL-1 increasednoradrenaline release in the
PVN of virgin, but not pregnant, rats. However, naloxone infused directly into the PVN increased noradrenaline release after IL-1 in
pregnant rats. Thus, the HPA axis responses to immune signals are suppressed in pregnancy at the level of pPVN CRH neurons through
an opioid mechanism, possibly acting by preterminal autoinhibition of NTS projections to the pPVN.
Keywords: ACTH; CRHmRNA; IL-1;-opioid receptor mRNA; noradrenaline; nucleus tractus solitarius; proenkephalin-A mRNA
Introduction
Responsiveness of the hypothalamic–pituitary–adrenal (HPA)
axis to psychogenic stressors is strongly attenuated during late
pregnancy (Neumann et al., 1998; Brunton et al., 2000; Johnstone
et al., 2000), but HPA axis responses in pregnancy to immune
challenge, a physical stressor, have not been reported. In non-
pregnant rats, HPA axis activation by immune challenge reflects
the bidirectional relationship between the immune and stress
axes (Besedovsky and Del Rey, 1992; Turnbull and Rivier, 1995;
Mulla andBuckingham, 1999), with a vital role of theHPA axis in
modulating immune responses (Turnbull and Rivier, 1995). Sys-
temic administration of endotoxin [lipopolysaccharide (LPS)]
increases corticotrophin releasing hormone (CRH) release
(Givalois et al., 1995), CRH mRNA expression in the hypotha-
lamic paraventricular nucleus (PVN) (Kakucska et al., 1993), and
adrenocorticotrophic hormone (ACTH) and corticosterone se-
cretion (Turnbull et al., 1998). LPS stimulates cytokine produc-
tion bymacrophages, hence increasing circulating cytokine levels
(Andersson et al., 1992), including interleukin-1 (IL-1), which
can mediate HPA responses to endotoxin (Besedovsky and Del
Rey, 1992). Accordingly, systemic administration of IL-1 po-
tently activates the HPA axis (Besedovsky and Del Rey, 1992;
Ericsson et al., 1994). The key role of PVN CRH neurons in this
response (Berkenbosch et al., 1987; Sapolsky et al., 1987; Rivest
and Rivier, 1991) involves their activation by direct noradrener-
gic projections from the brainstem A1 and A2 neurons in the
nucleus tractus solitarius (NTS) and ventrolateral medulla
(VLM) (Ericsson et al., 1994; Buller et al., 2001b), with the A2
neurons of primary importance (Ericsson et al., 1994; Buller et
al., 2001b). Systemic IL-1 stimulates these neurons (Ericsson et
al., 1994) by first acting on IL-1 type I receptors on the endothe-
lium of brain blood vessels to activate local production of pros-
taglandins (Ericsson et al., 1995; Rivest et al., 2000), which can
then excite the NTS neurons via EP3 and EP4 receptors (Zhang
and Rivest, 1999).
The attenuation of HPA axis responses to psychogenic stres-
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sors in pregnancy involves inhibition by a central endogenous
opioid mechanism that emerges in pregnancy (Douglas et al.,
1998). Possible sources of endogenous opioid that could regulate
PVN CRH neurons include noradrenergic NTS neurons, which
coexpress proenkephalin-A (pENK-A) mRNA (Ceccatelli et al.,
1989). -Opioid receptors mediate presynaptic inhibition of
noradrenaline release in the hypothalamus (Onaka et al., 1995);
thus, enkephalins may autoinhibit NTS neurons.
Here, we tested whether HPA axis responses to immune chal-
lenge are attenuated in late pregnancy and whether NTS neurons
respond to IL-1 in pregnant rats. We also investigated whether
differences in noradrenaline release in the PVN could account for
attenuated HPA axis responses and investigated a role for endog-
enous opioids. Finally, we established whether pENK-A and




Female Sprague Dawley rats (initial body weight, 260–290 g; Bantin and
Kingman,Hull, UK)weremaintained under standard conditions of tem-
perature (20–22°C), humidity, and lighting (12 h light/dark cycle; lights
on at 7:00 A.M.) with ad libitum access to food and water. Rats were
initially housed in groups of five to six and then caged individually after
surgery. Pregnant rats were obtained bymating overnight with a sexually
experienced male; pregnancy was confirmed by finding a vaginal plug of
semen on the cage floor the following morning (day 1 of pregnancy; day
22 of pregnancy is the expected day of parturition). Virgin rats were used
as controls. All procedures were performed in accordance with current
United Kingdom Home Office regulations.
Surgery: jugular vein cannulation
Five days before the experiment, virgin and day 16 pregnant rats were
fitted with a SILASTIC jugular vein cannula (wall, 0.25 mm; internal
diameter, 0.5 mm; filled with sterile heparinized 0.9% saline; 50 U/ml)
under inhalational anesthesia (2–3% halothane in 600 ml/min each of
oxygen and nitrous oxide) for subsequent blood sampling and drug
administration.
Blood sampling
On themorning of the experiment (between 7:30 and 9:00 A.M.), jugular
cannulas were connected to polyvinylchloride (PVC) extension tubing
(wall, 1mm; internal diameter, 0.5mm) filledwith heparinized saline (50
U/ml 0.9% saline) and attached to a 1 ml syringe for remote sampling.
Rats were then left undisturbed for 90 min. Blood samples for radioim-
munoassay (RIA) of ACTH (0.5 ml) or ACTH and corticosterone (0.6
ml) were collected into 1 ml syringes containing 20 l of 5% EDTA
chilled on ice and centrifuged to separate plasma, which was frozen and
stored at 20°C until assay. Each blood sample was replaced immedi-
ately with an equivalent volume of sterile 0.9% saline. Pregnancy status
was checked postmortem, and only pregnant rats with at least six viable
fetuses were included in the study (actual range, 9–18 pups). The timings
of blood samples for the different experiments are given below.
Experiment 1: ACTH responses to LPS
After two basal blood samples (0.5ml for ACTH) taken 15min apart, rats
were given either 1g/kg LPS endotoxin (Serotype 055:B5; 2g/ml, i.v.;
Sigma, Poole, Dorset, UK) or vehicle (0.9% saline, i.v.). Additional blood
samples were taken 60, 120, 180, and 240min after treatment. These time
points were deemed to be the most appropriate after reviewing the liter-
ature (Turnbull et al., 1998).
Experiment 2: HPA axis and NTS responses to IL-1
After two basal blood samples taken 30 min apart, rats were given either
500 ng/kg human recombinant (rh) IL-1 (1g/ml, i.v.; R & D Systems,
Oxon, UK) or vehicle [0.2% bovine serum albumin (BSA) in PBS]. Ad-
ditional blood samples were withdrawn 15, 30, 60, 90, and 120 min after
treatment. Rats were killed by conscious decapitation 4 h after treatment
(optimal time to measure PVN CRH mRNA expression after stimula-
tion) (Harbuz and Lightman, 1989). Trunk blood was collected into
tubes containing chilled 5% EDTA (0.2 ml/100 g body weight), and
plasma was separated and stored as above. The forebrains, brainstems,
and pituitary glands were rapidly removed, frozen on dry ice, and stored
at 70°C for CRH mRNA in situ hybridization (ISH), Fos immunocy-
tochemistry, and POMCmRNA ISH (to assess corticotroph exposure to
secretagogue), respectively.
To evaluate Fos expression in the NTS at 90 min after treatment (the
time for peak neuronal Fos expression after stimulation) (Sharp et al.,
1991), additional groups of pregnant and virgin rats were fitted with a
jugular cannula as before. Five days later (on day 21 of pregnancy), the
rats were given either 500 ng/kg rhIL-1 (1 g/ml, i.v.) or vehicle (0.2%
BSA in PBS) and killed 90 min later by conscious decapitation. Brain-
stems were rapidly removed, frozen on dry ice, and stored at70°C for
Fos immunocytochemistry.
Experiment 3: effects of naloxone on ACTH responses to IL-1
Pregnant (day 21) and virgin rats were implanted with a jugular vein
cannula as above. Immediately after the first basal blood sample was
taken (0.5 ml for ACTH RIA), rats were given 5 mg/kg naloxone (10
mg/ml) or 0.9% saline intravenously. After a second blood sample 15
min later, all rats were given 500 ng/kg rhIL-1 (1g/ml, i.v.). Additional
blood samples (0.5 ml for ACTH RIA) were taken 15, 30, 60, and 90 min
after IL-1 injection.
Experiment 4: effects of naloxone on PVN CRH mRNA responses
to IL-1
Pregnant (day 21) and virgin rats were used and were implanted with a
jugular vein cannula. The rats were given, as above, naloxone or vehicle
followed by IL-1 intravenously and killed by decapitation 4 h later.
Brains were rapidly removed, frozen on dry ice, and stored at70°C as
before for CRHmRNA ISH. These rats were blood sampled as above for
other measurements (not reported here).
Experiment 5: pregnancy and pENK-A mRNA and -opioid
receptor mRNA expression
Virgin,midpregnant (day 10), late-pregnant (day 21), parturient (90min
after the birth of the first pup), and lactating (days 7–10) rats were killed
by conscious decapitation. Brainstems were rapidly removed, frozen on
dry ice, and stored at70°C until processing for pENK-A and -opioid
receptor mRNA ISH. Brains were also collected from untreated virgin
and pregnant (d21) rats. Because enkephalin is coexpressed with CRH in
the parvocellular PVN (pPVN) (Hokfelt et al., 1983) and is also expressed
in the perifornical region (Khachaturian et al., 1983) (a region that may
influence PVN neuron responses), sections cut through the pPVN and
perifornical region were also processed for pENK-A mRNA ISH.
Experiment 6: effects of naloxone on IL-1-evoked noradrenaline
release in the PVN in virgin and pregnant rats
Surgery: implantation of microdialysis probe. Virgin and pregnant (day
18/19 of pregnancy) rats were anesthetized with halothane (as above),
and a U-shapedmicrodialysis probe (tip length, 1.4mm; dialysis surface,
2.4 mm2) (Landgraf and Ludwig, 1991) was implanted into the right
PVN [coordinates: caudal, 1.7 mm; lateral, 1.6 mm; 7.4 mm deep from
the brain surface; according to Paxinos andWatson (1996) at an angle of
10o to the vertical to avoid puncturing the sagittal sinus]. Probes were
secured in place with two jeweler’s screws fixed to the skull and dental
acrylic. Probes were flushed with sterile artificial CSF (aCSF) (inmM: 138
NaCl, 3.36 KCl, 9.52NaHCO3, 0.49Na2HPO4, 2.16 urea, 0.49NaH2PO4,
1.26 CaCl2, 1.18 MgCl2, pH 7.2). Lengths of fluorinated ethylene pro-
pylene (FEP) tubing (CMA Microdialysis, Solma, Sweden) were con-
nected to the probe inlet and outlet. Rats were also fitted with a jugular
vein cannula (as before) for administration of IL-1. After surgery, rats
were housed in commercially available purpose-designed Perspex bowls
(CMAMicrodialysis)with food andwater available ad libitum. Awire tether
extending from a swiveling lever-arm suspended over the bowl was clipped
to a collar placed around the rat’s neck, permitting free movement of the
animal without entangling/disconnection of the microdialysis tubing.
Microdialysis. Between 8:00 and 8:30 A.M., on the morning of the
experiment (2–3 d after surgery; i.e., day 20/21 of pregnancy), intrave-
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nous cannulas were connected to PVC extension tubing attached to a 1
ml syringe filled with heparinized saline. A length of FEP tubing con-
nected to a 1mlHamilton syringe prefilled with aCSFwas attached to the
inlet port of the probe. Hamilton syringes (1 ml) were secured in a
microinfusion pump. Probes were flushed with aCSF (flow rate, 1.5 l/
min) for 90 min before the experiment commenced. After flushing, mi-
crodialysis samples were collected at 15 min intervals. Three dialysate
samples were collected under basal conditions and then probes were
either perfused with aCSF or with aCSF containing naloxone (1 mg/ml)
for the remainder of the experiment. An additional three dialysate sam-
ples were collected and then all rats were administered IL-1 (500 ng/kg,
i.v.). Five additional dialysate samples were collected after IL-1 admin-
istration. In each case, dialysates were collected in chilled microdialysis
vials (covered in aluminum foil to minimize exposure to light) contain-
ing 2 l of 10% acetic acid (to prevent oxidation of monoamines) and
immediately after collection were frozen on dry ice and stored at70°C
until analysis. At the end of the experiment, rats were killed, and the
brains were removed, frozen on dry ice, and stored at 70°C until his-
tological processing. Coronal brain cryostat sections (15 m) were cut
through the hypothalamus, thaw-mounted onto glass microscope slides,
and stained with Toluidine blue to verify microdialysis probe location.
Only data from rats in which probes were correctly placed within the
PVN [with reference to plates 25–26 according to Paxinos and Watson
(1996)] are included in the results (see Fig. 7).
HPLC.Noradrenaline contents in the dialysates were quantified at The
Babraham Institute (Cambridge, UK) using reverse-phase HPLC with
electrochemical detection as described previously (Kendrick et al., 1996).
The detection sensitivity for a 10 l sample injection was 5–25 pg/ml.
Radioimmunoassays. Plasma ACTH and corticosterone concentra-
tions were determined using commercially available radioimmunoassay
kits (Immunodiagnostic Systems, Tyne andWear, UK). ACTHwasmea-
sured in unextracted plasma samples using a two-site immunoradiomet-
ric assay (Hodgkinson et al., 1984). Corticosterone was measured in
unextracted plasma (diluted 1:10 in assay buffer) using a double antibody
radioimmunoassay with 125I-corticosterone as the tracer (Keith et al.,
1978). For the ACTH and corticosterone assays, sensitivity was 1 pg/ml
and 0.4 ng/ml, respectively, and the intra-assay variation was 11 and
6%. All samples from any one experiment were assayed together.
In situ hybridization.Tissue was sectioned coronally on a cryostat at 15
m and thaw-mounted onto gelatinized slides. Sections were fixed with
4% (w/v) paraformaldehyde in 0.1 M PBS, washed in PBS, acetylated in
triethanolamine/acetic anhydride solution, dehydrated in an ascending
ethanol series (70–100%), delipidated in chloroform, and partially rehy-
drated in 95% (v/v) ethanol. All sections from a particular experiment
were processed in the same hybridization reaction, and in each case,
synthetic oligonucleotide probes were used (MWG-Biotech, Ebersberg,
Germany). To detect CRH mRNA expression in the PVN, a 42-mer
probe (5-CCT GTT GCT GTG AGC TTG CTG AGC TAA CTG CTC
TGC CCT GCC-3), complementary to bases 496–537, which encode
amino acids 22–35 of the rat CRH peptide (Jingami et al., 1985), was
used. The POMC probe was a 48-mer oligonucleotide (5-GGT CAT
GAA GCC GCC GTA GCG CTT GTC CTT GGG CGG GTT GCC CCA
GCG-3) complementary to rat POMC mRNA (Nakanishi et al., 1979).
The pENK-A probe was a 39-mer probe (5-TGC ATC CTT CTT CAT
GAAACCGCCATACCTCTTGGCAAG-3), complementary to bases
721–759 of pENK-AmRNA (Rosen et al., 1984), and the-opioid recep-
tor probe was 39-mer (5-TTC AGA CCG CAT GGA TCG GAC TGG
TTG CCA TCA ACG TGG-3) and complementary to bases 282–320 of
rat -opioid receptor mRNA (Chen et al., 1993).
Probes were 3-labeled with 35S-dATP using terminal deoxynucleoti-
dyl transferase and purified using spin columns (QIAquick nucleotide
removal kit; Qiagen, Crawley, West Sussex, UK). Sections were hybrid-
ized with radiolabeled probe (105 cpm labeled probe/section) in hybrid-
ization buffer [1% BSA (w/v), 5% dextran sulfate (w/v), 15 mM diothio-
threitol, 2 mM EDTA, 1% ficoll (w/v), 50% formamide (v/v), 0.1 mg/ml
PolyA, 1% polyvinylpyrrolidone (w/v), 0.2 mg/ml salmon testes DNA,
1.2 M sodium chloride, 2.5% sodium pyrophosphate (w/v), 20 mM Tris,
pH 7.6, 0.1 mg/ml yeast tRNA, 0.1 mg/ml yeast total RNA] overnight at
37°C in humidified chambers. Sections were rinsed three times in 1
SSC at room temperature, washed four times for 15 min each in 1 SSC
at 45–63°C (depending on hybridized probe melting temperature), and
twice for 30 min each at room temperature. Sections were air-dried and
exposed to autoradiographic film (Hyperfilm--max; Amersham Bio-
sciences, Buckinghamshire, UK) at room temperature, with 14C polymer
strip standards to check optimal exposure (Amersham Biosciences). Ex-
posure times were 21 and 14 d for CRH and POMCmRNA, respectively.
Film was then developed (Kodak D-19; Sigma) and fixed (Hypam rapid
fixer; Ilford, Cheshire, UK). Slides were dipped in liquid autoradio-
graphic emulsion (Kodak typeNTB-3; Anachem, Bedfordshire, UK) and
exposed (at 4°C) for 12 weeks for CRH mRNA and 21 d for pENK-A
mRNAand-opioid receptormRNA. Slides were developed and fixed as
above and counterstained with hematoxylin and eosin. The film autora-
diograms were quantified using a computerized image analysis system
(objectivemagnification, 2.5; NIH Image version 1.62). Grain area was
measured over a minimum of six PVN profiles (in three consecutive
sections) and six anterior pituitary sections from each rat for quantifica-
tion ofCRHandPOMCmRNAexpression, respectively. The area of each
profile was measured to calculate grain area/PVN or anterior pituitary
(square millimeter/square millimeter). Background measurements were
made over areas adjacent to the region of interest and subtracted. Mea-
surements over a 14C polymer strip were used to confirm that tissue
measurements were on the dynamic part of the radioactivity/silver grain
density curve.
The number of CRHmRNA-expressing cells in the PVN was counted
in emulsion-dipped sections. A positive cell was defined as onewithmore
overlying silver grains than the mean over 10 cells lateral to the PVN
(background) plus three SDs. Data are presented as the number of pos-
itive cells per square millimeter PVN profile. For quantitative analysis of
pENK-A and-opioid receptormRNAs in the NTS, silver grain area was
measured in 150–200 cells in the NTS per rat. Background measure-
ments were made over the equivalent of 20 cells in neuropil adjacent to
the NTS and subtracted. pENK-A mRNA expression in the pPVN was
determined by counting the number of positively expressing cells
(emulsion-dipped sections) and by measuring grain density over the
pPVN (film autoradiographs). Both were measured in a minimum of six
PVN profiles per rat.
Figure 1. The effect of intravenous LPS on plasma ACTH concentrations in virgin and preg-
nant (day 21) rats. Two basal blood samples (B)were collected 30min apart before intravenous
injection of either LPS (1g/kg) or vehicle (0.5 ml/kg; 0.9% saline). Additional blood samples
were withdrawn as shown. Values are group means SEM. Group numbers are as follows:
virgin/vehicle, n 10; pregnant/vehicle, n 7; virgin/LPS, n 11; pregnant/LPS, n 10.
Two-way ANOVA for repeated measures was used followed by Student–Newman–Keuls
multiple-comparison test: *p0.001versusbasal values in the samegroup; #p0.001versus
all other groups at the same time point.
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For all ISHmeasurements, average values for
each rat were used to calculate group means
SEM.
Fos immunocytochemistry. Coronal brain-
stem cryostat sections (15 m) cut through the
A2 cell region of theNTS (at the level of the area
postrema) were mounted on gelatinized slides.
Sections were fixed in 4% paraformaldehyde in
0.1 M phosphate buffer (PB), pH 7.3, for 30min
at room temperature, followed by three 5 min
washes in 0.1 MPB, pH7.4. Endogenous peroxi-
dases were deactivated with 1.5% hydrogen
peroxide in 0.1 M PB for 15 min and then sec-
tions were washed in PB containing 0.3% Tri-
ton X-100 (PB-T). Sections were incubated in
normal sheep serum (NSS) for 60 min before
incubation with rabbit anti-Fos (Ab-2) anti-
body (Calbiochem, La Jolla, CA) (diluted
1:1000 in PB-T containing 1% NSS and 0.02%
sodium azide; 750l/slide) at 4°C for 48 h. Sec-
tions were washed in PB-T (three times for 15
min each), incubated in excess (750 l/slide)
goat anti-rabbit peroxidase complex (Vector
Laboratories, Burlingame, CA), and diluted
1:500 in PB-T containing 1% NSS for 24 h at
4°C. Next, sections were washed three times for 15 min each in 0.1 M PB,
followed by a 10 min rinse in acetate buffer (0.33 M, pH 6.0). Sections
were incubated in acetate buffer (0.33 M, pH 6.0) containing 2.5% nickel
ammonium sulfate and 0.5% diaminobenzidine for 7–10 min until Fos-
immunoreactive nuclei were visualized. The reaction was terminated
with a 5 min wash in 0.165 M acetate buffer. Fos-positive cells were
manually counted bilaterally in 8–10 NTS sections per rat (VLM A1
neurons are not activated by IL-1 at the dose used) (Ericsson et al.,
1994). The area of the NTS profiles was measured using an AppleMac
computer (Apple Computers, Cupertino, CA) and NIH Image (version
1.62) software.
Statistical analysis. Two-way repeated-measures (RM) ANOVA, fol-
lowed by Student–Newman–Keuls multiple-comparison tests were used
to analyze ACTH, corticosterone, and noradrenaline data. CRHmRNA,
POMC mRNA, and Fos data were analyzed using a two-way ANOVA.
pENK-A and -opioid receptor mRNA data were analyzed using a one-
way ANOVA or Student’s t test. Values shown are group means SEM.
p 0.05 was considered statistically significant.
Results
Experiment 1: ACTH responses to LPS
Basal plasma ACTH concentrations (1.53  0.19 pg/ml in the
virgin rats, n 22 vs 0.87 0.21 pg/ml in the pregnant rats, n
17) were not significantly different between any of the groups
(Fig. 1) (two-way RM ANOVA). Intravenous LPS significantly
increased plasma ACTH concentration in the virgin group ( p
0.001; two-way RM ANOVA) within 60 min of the injection,
which peaked at 120min, and remained significantly elevated 240
min after LPS administration. However, LPS evoked only a small,
nonsignificant increase in plasma ACTH concentration in the
pregnant group (Fig. 1). Vehicle injection had no significant ef-
fect on plasma ACTH in either the virgin or the pregnant rats
(Fig. 1).
Experiment 2: HPA axis and NTS responses to
intravenous IL-1
To circumvent the possibility that changes in endogenous cyto-
kine generation may underlie the attenuated response to LPS in
pregnancy, we measured HPA responses to IL-1 in subsequent
experiments. Basal plasmaACTHconcentrationswere not signif-
icantly different between any of the groups (Fig. 2a) ( p  0.05;
two-way RM ANOVA). Intravenous IL-1 rapidly increased
ACTH secretion within 15min in the virgin group (Fig. 2a) ( p
0.001; two-way RM ANOVA), which remained significantly ele-
vated for at least 120 min after IL-1, returning to baseline levels
within 240 min. In contrast, in the pregnant group, IL-1 in-
duced only a nonsignificant increase (1.7-fold; p 0.093 and p
0.084; two-way RM ANOVA vs basal and pregnant vehicle-
treated groups, respectively) in plasma ACTH concentration 30
min after the injection (Fig. 2a). Plasma ACTH concentrations in
the pregnant group were significantly less than those in the virgin
group at all time points measured after IL-1 ( p  0.001; two-
way RMANOVA). Vehicle injection did not affect plasmaACTH
concentrations in either the virgin group or the pregnant group
(Fig. 2a).
Basal plasma corticosterone concentration was not signifi-
cantly different between groups (Fig. 2b) ( p 0.05; two-way RM
ANOVA). After IL-1 administration, plasma corticosterone
concentration increased significantly within 30 min in the virgin
group and was still significantly greater than basal at 240 min
( p  0.001; two-way RM ANOVA). Intravenous IL-1 had no
significant effect on plasma corticosterone concentration in the
pregnant group (Fig. 2b). Vehicle injection had no significant
effect on plasma corticosterone concentration in either group.
POMCmRNA expression in the anterior pituitary was similar
in the vehicle-treated virgin and pregnant rats. IL-1 treatment
significantly increased POMC mRNA expression in virgin rats
(Fig. 3a) ( p 0.001; two-way ANOVA) but had no such effect in
pregnant rats (Fig. 3a).
Four hours after IL-1 treatment, CRH mRNA expression
(measured as grain density and number of positive cells) in the
dorsomedial pPVN was significantly increased in the virgin
group (Fig. 3) ( p  0.001; two-way ANOVA), but there was no
significant change in CRH mRNA expression in the pregnant
group (Fig. 3). CRH mRNA expression in the PVN was not sig-
nificantly different between the virgin and pregnant control rats
(Fig. 3) ( p 0.233; two-way ANOVA).
IL-1 significantly increased Fos expression in the A2 cell
region of the NTS of both virgin and pregnant rats killed 90 min
(Fig. 4a,b) or 240 min (Fig. 4c) after treatment; however, there
were no significant differences in the number of Fos-positive
neurons between the virgin and pregnant IL-1-treated groups.
Figure 2. Effects of intravenous IL-1 on plasmaACTH and corticosterone concentrations in virgin and pregnant (day 21) rats.
Basal blood samples (B)were collected for ACTHand corticosteroneRIA before intravenous injection of either rhIL-1 (500ng/kg)
or vehicle (0.5 ml/kg 0.2% BSA in PBS). Additional blood samples were withdrawn for ACTH (a) and corticosterone (b) RIA as
shown. Trunk bloodwas collected at 240min. Values are groupmeans SEM. Group numbers are as follows: virgin/vehicle, n
9; pregnant/vehicle, n 6; virgin/IL-1, n 8; pregnant/IL-1, n 7. Two-way ANOVA for repeated measures was used
followed by Student–Newman–Keuls multiple-comparison test: *p 0.001 versus basal values in the same group; #p 0.005
versus all other groups at the same time point.
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There were no significant differences in the number of Fos-
immunopositive NTS neurons between the virgin and pregnant
groups after vehicle (Fig. 4).
Experiment 3: effects of naloxone on ACTH responses
to IL-1
Basal plasma ACTH concentrations were not significantly differ-
ent between any of the groups, and neither naloxone nor vehicle
injection significantly affected basal plasma ACTH levels in any
of the groups (Fig. 5a) (two-way RM ANOVA). IL-1 rapidly
increased plasma ACTH concentration in the vehicle-treated vir-
gin group, which peaked within 15min (63.5 2.8 pg/ml); how-
ever, there was no significant change in the vehicle-treated preg-
nant group (17.9 3.5 pg/ml). Pretreatment with naloxone had
no significant effect on the ACTH secretory response to systemic
IL-1 in the virgin group (Fig. 5a). In contrast, in the pregnant
group given naloxone, there was a significant ACTH response to
IL-1 ( p 0.001 vs basal levels; p 0.002 vs pregnant vehicle-
treated group at 15min; two-way RMANOVA), althoughACTH
concentrations were significantly less than
those in the virgin groups (Fig. 5a) at all
sample times after IL-1.
Experiment 4: effects of naloxone on
PVNCRHmRNA responses to IL-1
CRH mRNA expression in the pPVN 4 h
after IL-1 treatment was 7.4-fold greater
in the virgin vehicle-pretreated rats than in
the pregnant vehicle-pretreated rats (Fig.
5b,c) ( p 0.001; two-way ANOVA). Nal-
oxone pretreatment significantly in-
creased CRH mRNA expression in re-
sponse to IL-1 in the pregnant group
( p  0.001 vs pregnant/vehicle group;
two-way ANOVA) but significantly re-
duced CRHmRNA expression in response
to IL-1 in the virgin group ( p 0.001 vs
virgin/vehicle group; two-way ANOVA).
There were no differences in CRH mRNA
expression between the virgin and preg-
nant IL-1-treated groups pretreated with
naloxone ( p 0.457; two-way ANOVA).
Experiment 5: pENK-AmRNAexpression
in the pPVN, perifornical region and
NTS, and-opioid receptor mRNA
expression in the NTS in pregnancy
pENK-A mRNA expression in the NTS
was significantly greater on day 21 of preg-
nancy compared with virgin and lactating
rats (Fig. 6a,b) ( p  0.01; one-way
ANOVA). There was no significant dif-
ference in the level of pENK-A mRNA
expression in either the pPVN or the peri-
fornical region between virgin and late-
pregnant rats (Table 1) ( p 0.50 and p
0.58, respectively; Student’s t test).
-Opioid receptor mRNA expression in
the NTS was significantly increased in
pregnant, parturient, and lactating rats
versus virgin controls; peak expressionwas
at parturition (Fig. 6c,d) ( p 0.001; one-
way ANOVA).
Experiment 6: effects of naloxone on IL-1-evoked
noradrenaline release in the PVN in virgin and pregnant rats
Effect of IL-1 on noradrenaline release in the PVN of virgin
and pregnant rats
Basal noradrenaline levels were not significantly different be-
tween the virgin group (513  149.8 pg/ml) and the pregnant
group (618.5  206.3 pg/ml; Student’s t test; p  0.466). Statis-
tical analysis of log transformed basal noradrenaline data (to re-
duce variance) also showed no significant difference between vir-
gin and pregnant rats (Student’s t test; p 0.20). Systemic IL-1
administration evoked a significant increase in noradrenaline
release in the PVN of virgin rats but not pregnant rats (Fig. 7a)
(two-way RM ANOVA; p 0.001); to control for interanimal
variability, data were normalized as a percentage of within-rat
mean basal values calculated from the six samples before
IL-1.
Figure 3. Effects of intravenous IL-1 on anterior pituitary POMCmRNA and parvocellular PVN CRHmRNA expression in virgin
and pregnant (day 21) rats. In situ hybridization for POMC mRNA in the anterior pituitary (a) and CRH mRNA (b–d) in the
dorsomedial parvocellular PVN in 15mcoronal sections from rats killed 4 h after intravenous injection of either rhIL-1 (IL-1B;
500 ng/kg) or 0.2%BSA in PBS (0.5ml/kg).a, POMCmRNA: grain areameasurementsweremade from film autoradiographs over
the anterior pituitary. b, Representative dark-field autoradiographs of coronal PVN sections hybridized with an 35S-labeled
oligonucleotide probe complementary to CRHmRNA from each group: A, virgin/vehicle; B, virgin/IL-1; C, pregnant/vehicle; D,
pregnant/IL-1. 3V, Third ventricle;mgPVN,magnocellular subdivision of PVN. Scale bar, 100m. c, CRHmRNA:measurements
of grain density weremade from film autoradiographs over the pPVN. d, Number of pPVN cells expressing CRHmRNA. Values are
group means SEM. Group numbers are as follows: virgin/vehicle, n 10; pregnant/vehicle, n 11; virgin/IL-1, n 8;
pregnant/IL-1, n 7. Two-wayANOVAwas used followed by Student–Newman–Keulsmultiple-comparison test: *p 0.001
versus control groups; #p 0.001 versus virgin/IL-1 group.
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Effect of naloxone treatment on IL-1-
evoked noradrenaline release in the
PVN of virgin and pregnant rats
In the pregnant rats, naloxone treatment
alone had no significant effect on nor-
adrenaline release in the PVN (Fig. 7b) (for
analysis of effects of naloxone, data before
naloxone and after IL-1were normalized
to themeanof the three post-naloxonemi-
crodialysate noradrenaline contents). Af-
ter stimulation with IL-1, noradrenaline
release in the PVN was significantly in-
creased in the pregnant rats pretreated
with naloxone (two-wayRMANOVA; p
0.02 at peak), contrasting with the lack of a
significant effect of IL-1 on noradrena-
line release in the PVNof the pregnant rats
pretreated with vehicle (Fig. 7b).
Naloxone treatment alone had no sig-
nificant effect on noradrenaline release in
the virgin rats. In virgin rats, naloxone had
no significant effect on noradrenaline re-
lease in the PVN after IL-1 administra-
tion, which was indistinguishable from
that observed in the virgin rats treatedwith
IL-1 only (data not shown).
Discussion
Our results demonstrate that in late preg-
nancy, the HPA axis is almost nonrespon-
sive to immune challenge with systemic
endotoxin or IL-1 as a result of endoge-
nous opioid inhibition of pPVN CRH
neurons. This inhibition may be exerted
by enkephalins produced by NTS neurons
and acting via -opioid receptors on nor-
adrenergic terminals in the PVN. The re-
sults complement findings of reduced
HPA responses in pregnancy to emotional
stressors (Douglas et al., 1998; Neumann
et al., 1998; Johnstone et al., 2000) and to
orexin (Brunton and Russell, 2003), indi-
cating global suppression of CRH neuron
responses to stressors in late pregnancy.
We showed HPA axis activation by in-
travenous LPS in virgin females as in male
rats (Turnbull et al., 1998). In late preg-
nancy, the ACTH secretory response to LPS was strongly attenu-
ated. It is not known whether direct LPS actions on the brain
(Chakravarty and Herkenham, 2005) are involved in HPA axis
responses or altered in pregnancy. The reduced ACTH response
to LPS in late pregnancy was not a result of reduced cytokine
generation by immune cells, because the ACTH and corticoste-
rone responses to IL-1 were also suppressed. The attenuated
ACTH response to LPS or IL-1 is not attributable to failure of
corticotrophs to respond to secretagogues in pregnancy (Ma et
al., 2005), nor is metabolic clearance of corticosterone enhanced
(Waddell and Atkinson, 1994). The attenuated ACTH and corti-
costerone responses to immune challenge result from reduced
CRH drive (and/or vasopressin, although CRH predominates)
(Turnbull et al., 1998) by the pPVN, becauseCRHmRNAexpres-
sion in the pPVNwas not stimulated by intravenous IL-1 in late
pregnancy in contrast with virgin rats. Increased pPVN CRH
mRNA expression after IL-1 indicates stimulation of the CRH
neurons, which releases CRH from the axon terminals in the
median eminence (Herman and Morrison, 1996). As CRH in-
creases anterior pituitary POMCmRNA expression (Bruhn et al.,
1984), the increase after IL-1 only in virgin rats indicates greater
corticotroph exposure toCRH in virgin rats than in late-pregnant
rats. Moreover, intracerebroventricular IL-1 depletes median
eminence CRH in virgin rats but not in pregnant rats (Nakamura
et al., 1998).
Reduced activation of CRH mRNA expression in late preg-
nancy after IL-1 is probably a consequence of altered input from
brainstem noradrenergic neurons. Noradrenaline excites CRH
neurons (Cole and Sawchenko, 2002), and CRH mRNA expres-
sion is tonically stimulated by noradrenergic and adrenergic
pathways (Kiss et al., 1996). Here, increased noradrenaline re-
lease in the PVN of virgin rats, but not late-pregnant rats, after
Figure4. Effect of intravenous IL-1onFos expression in theA2 cell regionof theNTS in virgin andpregnant (day21) rats. Rats
weregiveneither rhIL-1 (500ng/kg, i.v.) or vehicle (0.5ml/kg, i.v.; 0.2%BSA inPBS) andkilledafter 90min (a,b) or 4h (c) (same
rats as in Fig. 2). Cryostat 15mcoronal brainstem sections were processed for Fos immunocytochemistry. a, Photomicrographs
of representative sections showing neuronal nuclei immunoreactive for Fos (at 90 min) in the NTS from each group: A, virgin/
vehicle; B, pregnant/vehicle; C, virgin/IL-1; D, pregnant/IL-1. Low-magnification images are shown for pregnant/vehicle (E)
and pregnant/IL-1 (F ). NTS, A2 cell region of the NTS; CC, central canal; 10, dorsal motor nucleus of vagus; 12 hypoglossal
nucleus. Scale bar, 100m. b, c, Fos-positive cells were counted in the A2 cell region of the NTS at the level of the area postrema,
13.5–14.2 mm caudal to bregma according to the study by Paxinos and Watson (1996), and the area of the NTS profile was
measuredusingNIH Image1.62 software. Thedata are expressed as thenumber of Fos-positive cells per squaremillimeter. Values
are group means SEM. b, Ninety minutes. Group numbers are as follows: virgin/vehicle, n 6; pregnant/vehicle, n 7;
virgin/IL-1, n 6; pregnant/IL-1, n 8. c, Four hours. Group numbers are as follows: virgin/vehicle, n 10; pregnant/
vehicle, n 11; virgin/IL-1, n 7; pregnant/IL-1, n 7. Two-way ANOVAwas used followed by Student–Newman–Keuls
multiple-comparison test: *p 0.001 versus vehicle groups.
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IL-1 may explain the differences in CRH neuron activation. A
putative source of this noradrenaline is the brainstem NTS neu-
rons, which project directly to the PVN, relaying peripheral in-
formation to CRH neurons after immune activation (Ericsson et
al., 1994; Buller et al., 2001b). Lesioning this noradrenergic pro-
jection (with 6-hydroxydopamine) abolishes increased PVN
CRHmRNA expression and reduces ACTH secretion after intra-
venous IL-1 (Melik Parsadaniantz et al., 1995). Our findings of
suppressed noradrenaline release in the PVN after immune chal-
lenge in late pregnancy are consistent with studies in lactation,
when the HPA axis is also hyporesponsive (Toufexis et al., 1998).
We found similar numbers of Fos-expressing neurons in theNTS
A2 region (the location of noradrenaline cells projecting to the
dorsomedial PVN) after intravenous IL-1 in virgin and late-
pregnant rats, indicating intact IL-1 signaling to the NTS in late
pregnancy. Thus, signaling from brainstem blood vessels after
systemic IL-1 [involving prostaglandin generation via cycloox-
ygenase (COX)] (Rivest et al., 2000) is unlikely to be suppressed
in late pregnancy.We propose that reduced signaling by systemic
IL-1 is at the level of the pPVN CRH neurons, including the
terminals of theNTS projection. Altered intrahypothalamicCOX
signaling in pregnancy, underlying reduced LPS-induced fever
responses (Mouihate et al., 2002), might contribute to reduced
pPVN CRH neuron activation after systemic IL-1. NTS and
VLM catecholamine cells may also mediate HPA responses to
systemic IL-1 indirectly via the central amygdala and bed nu-
cleus of stria terminalis (Buller et al., 2001a), and signaling
through this pathway might be suppressed in pregnancy.
Naloxone reinstated an ACTH response to IL-1 in late-
Figure 5. The effect of pretreatment with naloxone on plasma ACTH and parvocellular PVN
CRHmRNAexpression after intravenous IL-1 in virgin andpregnant (day 21) rats.a, One basal
blood sample (B) was collected before administration of either naloxone (5 mg/kg, i.v.; 10
mg/ml) or vehicle (0.5 ml/kg, i.v.; 0.9% saline). A blood sample was withdrawn 15 min after
naloxone/vehicle injection and then rhIL-1 (500 ng/kg, i.v.; 1g/ml) was given to all rats.
Sequential blood samples were taken after IL-1 as shown. Values are group means SEM.
Groupnumbers are as follows: virgin/vehicle,n7; pregnant/vehicle,n6; virgin/naloxone,
n 8; pregnant/naloxone, n 6. Two-way ANOVA for repeatedmeasures was used followed
by Student–Newman–Keuls multiple-comparison test: *p 0.001 versus basal values in the
same group; #p 0.02 versus all other groups at the same time point; 	p 0.004 versus
virgin groups at the same time point. b, c, Four hours after the IL-1 injection, the rats were
killed. Cryostat 15m coronal brain sections were hybridized with an 35S-labeled oligo-probe
complementary to CRH mRNA. b, Representative film autoradiographs, bright-field, exposed
for 21 d from group: A, virgin/vehicle; B, virgin/naloxone; C, pregnant/vehicle; D, pregnant/
naloxone. 3V, Third ventricle; pPVN, dorsomedial parvocellular subdivision of PVN. Scale bar,
100 m. c, Measurements of grain area per unit area of pPVN profile (grain density) in film
autoradiographs. Values are group means SEM. Group numbers are as follows: virgin/vehi-
cle, n 6; pregnant/vehicle, n 6; virgin/naloxone, n 6; pregnant/naloxone, n 7.
Two-way ANOVA was used followed by Student–Newman–Keuls multiple-comparison test:
*p 0.001 versus all other groups.
Figure 6. pENK-A and -opioid receptor mRNA expression in the NTS. Cryostat 15 m
coronal brainstem sections were hybridized with 35S-labeled oligonucleotides probes comple-
mentary to pENK-A or-opioid receptor mRNA. a, Representative autoradiographs in bright-
field showing cells in the NTS-expressing pENK-A mRNA from: A, virgin; B, day 21 pregnant
groups. Open arrows indicate examples of a pENK-A mRNA-expressing cell. Midline is to the
right of the field. Scale bar, 50 m. b, Measurements of silver grains per neuron. Values are
groupmeans SEM. Groupnumbers are as follows: virgin,n 6; day 10 pregnant,n 6; day
21 pregnant, n 6; parturient, n 6; lactating, n 5. One-wayANOVAwas used followedby
Student–Newman–Keuls multiple-comparison test: *p  0.01 versus virgin and lactating
group. c, -Opioid receptor mRNA expression in the NTS: measurements of silver grains per
neuron. Values are group means SEM. Group numbers are as follows: virgin, n 6; day 10
pregnant, n 6; day 21 pregnant, n 6; parturient, n 6; lactating, n 6. One-wayANOVA
was used followed by Student–Newman–Keuls multiple-comparison test: *p 0.001 versus
virgin group; #p 0.01 versus all other groups. d, Representative autoradiographs showing
cells in the NTS-expressing -opioid receptor mRNA from the following: A, virgin; B, day 21
pregnant groups. Open arrows indicate an example of a-opioid receptor mRNA-expressing
cell. Scale bar, 50m.
Brunton et al. • Immune Challenge and the HPA Axis in Pregnancy J. Neurosci., May 25, 2005 • 25(21):5117–5126 • 5123
pregnant rats, which strongly indicates a role for endogenous
opioids in the attenuated response to systemic IL-1. Naloxone
also increases ACTH secretion after forced swimming in late
pregnancy (Douglas et al., 1998) and during parturition (Wigger
et al., 1999). Reduced corticotroph responses to CRH may ex-
plain the still-reduced ACTH secretory response to IL-1 in late-
pregnant rats after naloxone (Neumann et al., 1998; Ma et al.,
2005). However, a central inhibitory action of opioids in late
pregnancy was clearly indicated, because naloxone triggered a
pPVN CRH mRNA response to IL-1 and, infused directly into
the PVN, naloxone restored IL-1-evoked noradrenaline release
in late-pregnant rats. In contrast, naloxone reduced the pPVN
CRH mRNA response to IL-1 in virgin rats but not the ACTH
response; naloxone reduces the ACTH response to swim stress in
virgin rats (Douglas et al., 1998). The inferred excitation by en-
dogenous opioids of HPA axis responses in virgins is consistent
with potentiation of HPA stress responses by morphine (Buck-
ingham, 1982) and stimulation of CRH release by enkephalins
(Buckingham, 1982). Hence, we deduce that endogenous opioids
promote pPVNCRHneuron stress responses in virgin rats; how-
ever, in late pregnancy, a dominant inhibitory opioidmechanism
is activated, attenuating pPVN CRH neuron and, hence, ACTH
secretory responses.
Naloxone does not distinguish the opioid receptor type(s)
mediating the opposing effects on HPA activity in virgin and
pregnant rats. However, the hypothalamus is almost devoid of
-receptors (Mansour et al., 1987), and selective -receptor an-
tagonists abolish ACTH stress responses in male rats (Cover and
Buckingham, 1989), whereas blockade of-receptors exaggerates
stress responses (Cover and Buckingham, 1989). Thus, in the
present study, naloxonemay have attenuated pPVNCRHmRNA
responses to IL-1 in virgins via -receptors. However, the cen-
tral endogenous opioid inhibition of oxytocin secretion that
emerges in pregnancy is exerted via - not -receptors (Douglas
et al., 1995). Furthermore, -receptors mediate attenuated HPA
responses to IL-1 in male rats treated chronically with mor-
phine (Chang et al., 1996), indicating the potential for inhibitory
actions via -receptors.
The present finding of increased -opioid receptor mRNA
expression in the NTS of pregnant rats is consistent with
-receptor mediation of endogenous opioid inhibition of pPVN
CRHneuron activation by IL-1. Upregulated-opioid receptor
production in NTS neurons could lead to increased transport to
their terminals in the hypothalamus, where -opioid inhibits
noradrenaline release in the supraoptic nucleus (Onaka et al.,
1995). HPA axis hyporesponsiveness to immunological stressors
in lactation (Shanks et al., 1999) and late pregnancy is likely a
result of different mechanisms, because in the present study,
proenkephalin-AmRNA expression in the brainstemwas similar
in virgin and lactating rats.
There are several possible sources of central endogenous opi-
oid restrain that CRH neuron responses in pregnancy, including
the arcuate nucleus, pPVN CRH neurons, perifornical region,
and the NTS neurons themselves. Arcuate nucleus -endorphin
cells project directly to the PVN (Sawchenko et al., 1982), and in
late pregnancy, POMC mRNA and -endorphin expression in
the arcuate nucleus are increased (Douglas et al., 2002).However,
arcuate neurons are unlikely to mediate the immediate opioid
actions on responses to systemic IL-1, because they respond
later thanNTS and pPVNneurons (Brady et al., 1994). Enkepha-
lin is expressed in the perifornical region and is coexpressed with
CRH in pPVN cells, but here we showed that pENK-A mRNA
expression is not increased in either the pPVN or perifornical
region in late pregnancy. Furthermore, because these pPVN cells
are not activated in pregnant rats after IL-1, autoinhibition of
pPVN neurons by enkephalin seems implausible.
The NTS is a more likely source of opioids that inhibit pPVN
CRH neuron responses to IL-1. Enkephalins and dynorphins
are synthesized by NTS neurons (Ceccatelli et al., 1989, 1992).
Thus, if the NTS neurons showing upregulated pENK-A mRNA
expression in pregnancy include noradrenergic neurons project-
ing to the PVN (Ericsson et al., 1994), their activation by IL-1 is
expected to release more enkephalin from their terminals to act
on the upregulated -opioid receptors. Hence, the proposed site
of naloxone action in pregnancy is the brainstem noradrenergic
nerve terminals in the PVN, as supported by increased noradren-
Table 1. Proenkephalin-AmRNA expression in the pPVN and perifornical region in virgin and pregnant (day 21) rats
pPVN Perifornical region
Group Number of positive cells Grain density (arbitrary units) Number of positive cells Grain density (arbitrary units)
Virgin 36.1 6.5 (n10) 0.249 0.02 (n8) 29.1 3.2 (n 9) 0.317 0.03 (n8)
Pregnant (day 21) 40.9 3.2 (n11) 0.234 0.01 (n8) 31.9 3.6 (n11) 0.310 0.03 (n8)
Coronal brain sections (15m)were hybridizedwith an 35S-labeled oligonucleotide probe complementary to pENK-AmRNA. Values are themean (SEM) number of cells in the pPVN and perifornical region expressing pENK-AmRNA and
mean (SEM) grain density over these regions.
Figure 7. The effect of IL-1 and naloxone pretreatment on noradrenaline release in the
PVN of virgin and pregnant (day 21) rats. a, Six basal 15min dialysates were collected, and the
within-ratmean of these values was taken as 100% (B) and then rats were administered IL-1
(500 ng/kg, i.v.; 1g/ml; rh). An additional five dialysates (15 min each) were collected, and
values were calculated as percentage of mean basal for each rat. Values are group means
SEM. Group numbers are as follows: virgin, n 8; pregnant, n 7 rats. Two-way ANOVA for
repeated measures was used followed by Student–Newman–Keuls multiple-comparison test:
*p 0.001 versus basal values in the same group; #p 0.001 versus other group at the same
time point. Inset, Representative photomicrograph of a Toluidine blue-stained coronal section
(15m) cut through the hypothalamus after postmortem removal of the microdialysis probe.
The probe tip is located in the dorsomedial parvocellular region of the PVN. Scale bar, 250m.
b, Three basal dialysates were collected and then rats were treated with either naloxone (NLX;
1 mg/ml retrodialyzed directly into PVN) or vehicle (aCSF). Three additional dialysates were
collected [the mean of these 3 samples was taken as 100% for each rat (sample 2), and the 3
preceding basal samples were normalized to sample 2 (B)] and then all rats were administered
IL-1 (500 ng/kg, i.v.; rh). Five additional dialysates were collected at 15 min intervals [these
valueswerenormalized to themeanof the3postnaloxoneor vehicle values for each rat (sample
2)]. Values are group means SEM. Group numbers are as follows: pregnant/vehicle, n 7;
pregnant/naloxone, n 6 rats. Two-way ANOVA for repeatedmeasures was used followed by
Student–Newman–Keuls multiple-comparison test: *p 0.05 and #p 0.001 versus other
group at the same time point.
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aline release after systemic IL-1 during local naloxone applica-
tion in pregnant rats.
In conclusion, in late pregnancy, HPA axis responsiveness to
LPS and IL-1 is markedly attenuated, resulting from reduced
drive by pPVNCRHneurons. This seemsnot to be a consequence
of interrupted signaling to NTS neurons in pregnancy but is par-
simoniously proposed to be through upregulated presynaptic au-
toinhibitory endogenous opioid action on the brainstem norad-
renergic projection to the CRH neurons, suppressing
noradrenaline release. Reduced HPA responses to immune chal-
lenge in pregnancy will protect the fetuses from excessive glu-
cocorticoid exposure, which can cause adverse programming and
may also underlie the altered incidence of autoimmune disorders
in pregnancy (Dunna and Finlay, 1989; Runmarker and
Andersen, 1995; Ostensen and Villiger, 2002).
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